Prevalence and Patterns of Hearing Loss among Chronic Kidney Disease of Various Stages in Bangladeshi Patients

Rezwanur Rahman¹, Nayareen Akhtar^2, , Asia Khanam³ and Muhammad Rafiqul Alam³

¹Department of Nephrology, Bangladesh Medical College & Hospital

²Department of Microbiology, Delta Medical College

³Department of Nephrology, Bangabandhu Sheikh Mujib Medical University

Cite this paper:
Rezwanur Rahman, Nayareen Akhtar, Asia Khanam and Muhammad Rafiqul Alam. Prevalence and Patterns of Hearing Loss among Chronic Kidney Disease of Various Stages in Bangladeshi Patients. American Journal of Medical Sciences and Medicine. 2016; 4(3):53-58. doi: 10.12691/ajmsm-4-3-2

Abstract

Objectives: This study was designed to evaluate the association between chronic kidney disease and sensorineural hearing impairment. Early detection of sensorineural hearing imapirment in CKD patient will allow appropriate treatment which will improve quality of hearing. Hypothesis: Sensorineural hearing impairment is more prevalent in chronic kidney disease patients than control group. Setting: The work was done at a tertiary level hospital in the central part of country. Participants: The subjects were divided into a case group consisting of 55 CKD patients and a control group of 50 people. Subjects with age below 18 years and above 60 years, AKI, audiometric evidence of conductive hearing loss & past medical or surgical treatment of otologic conditions were excluded from the study. Results. Prevalence of sensorineural hearing loss in CKD patients was found to be 54% and the prevalence of hearing loss in control subjects was found to be 16%. Comparison of hearing loss between CKD and the control groups was found to be statistically strongly significant (p value was 0.0004). In CKD patients, 10 % had mild loss of hearing impairment, 30 % had moderate loss, severe loss was present in 40% patients and 20% had profound loss of hearing. By disease stage, the prevalence of hearing loss in CKD patients was as follows: stage III, 6.6%; stage IV, 33.3% and stage V 60 %. Conclusion: The present study showed the relationship between chronic kidney disease and sensorineural hearing impairment to be statitistically significant (P<0.05) which signifies that that hearing loss is relatively prevalent in patients with CKD.

Keywords:
CKD hearing loss

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Thodi Chryssoula, Elias Thodis, Vassilis Danielides, Ploumis Pasadakis and Vassilis Vargemezis., 2006. Hearing in renal failure. Nephrol Dial Transplant, Volume 21, pp. 3023-3030.
[2]	Quick CA, Fish A, Brown C. The relationship betweencochlea and kidney. Laryngoscope 1973; 83: 1469-82.
[3]	Zeigelboim BS, Mangabeira-Albernaz PL, Fukuda Y. High frequency audiometry and chronic renal failure. Acta Otolaryngol 2001; 121:245-8.
[4]	Ozturan O, L. S., 1998. The effect of haemodialysis on hearing using pure tone audiometry and distortion product otoacoustic emissions. ORL J Otorhinolaryngol Relat spec, Volume 60, pp. 306-13.
[5]	Stavroulaki P, Nikolopoulos TP, Psarommatis I, Apostolopoulos N., 2001. Hearing evaluation with distortionproduct otoacoustic emissions in young patients undergoing haemodialysis. Clin Otolaryngol Allied Sci, volume 26, pp.235-42.
[6]	Antonelli A.R, Bonfioli F, Garrubba V, Ghisellini., 1990. Audiological findings in elderly patients with chronic renal failure. Acta Otolaryngol Suppl, volume 476, pp. 54-68.
[7]	Orendorz-Fraczkowska K, Medynska A, Jablonka A, Gawron W. 2008.Hearing organ function in children with nephritic syndrome in the course of primary glomerulopathy. Otolaryngol Pol, volume 62, pp.182-7.
[8]	Eggermont, Jos J.; Burkard, Robert F.; Manuel Don (2007). Auditory evoked potentials: basic principles and clinical application. Hagerstwon, MD: Lippincott Williams & Wilkins.
[9]	Hall, James W. (2007). New handbook of auditory evoked responses. Boston: Pearson.
[10]	Moore, Ernest J (1983). Bases of auditory brain stem evoked responses. New York: Grune & Stratton.
[11]	Mancini M. L, Dello S.L, Bianchi P.M, L. Tieri, G., 1996. Rizzoni Sensorineural hearing loss in patients reaching chronic renal failure in childhood. Pediatr Nephrol, volume 1, pp. 38-40.
[12]	Kakarlapudi V, S. R. S. H., 2003. The effect of diabetes on sensorineural hearing loss.. Otol Neurotol, 24(3), pp. 382-386.
[13]	Mitchell P, Gopinath B, McMahon CM, E. Rochtchina., 2009. Relationship of type 2 diabetes to the prevalence, incidence and progression of age-related hearing loss. Diabet Med, volume 26(5), pp.483-488.
[14]	Duck SW, Prazma J, Bennett PS, Pillsbury HC., 1997. Interaction between hypertension and diabetes mellitus in the pathogenesis of sensorineural hearing loss. Laryngoscope, 107(12), pp.1596-1605.
[15]	Verdel BM, V. P. E. S. P. E. A., 2008. Drug related nephrotoxicity and ototoxicity reaction. Drug Saf, 26(5), pp. 382-386.
[16]	Pirodda A, Saggese D, Ferri GG, Giausa G, Grippo MC, Gaddi A., 1997. The role of hypotension in the pathogenesis of sudden hearing loss. Audiology,volume 36, pp.98-108.
[17]	Borghi C, Cosentino ER, Rinaldi ER, Brandolini C, Raimondi MC, Veronesi M., 2011. Tinnitus in elderly patients and prognosis of mild-to-moderate congestive heart failure patients: a cross-sectional study with a long-term extension of the clinical follow-up. BMC Med, volume Jun 29, pp. 980.
[18]	Degli Esposti D, Raimondi MC, Dormi A, Cosentino ER, Bacchelli S, Brandolini C., 2009. Hemodynamic profile of young subjects with transient tinnitus. Audiol Med, volume 7, pp.200-4.
[19]	Pirodda A, Cicero AFG, Borghi C., 2012. Kidney disease and inner ear impairment: a simpler and closer analogy? Intern Emerg Med, volume 7, pp. 93-95.
[20]	Nakashima T, Naganawa S, Sone M, Tominaga M, Hayashi H, Yamamoto H., 2003. Disorders of the cochlear blood flow. Brain Res Brain Res Rev, volume 43, pp.17-28.
[21]	Smilde TD, Damman K, van der Harst P, Navis G, Westenbrink BD, Voors AA. 2009. Different associations between renal function and “modifiable” risk factors in patients with chronic heart failure. Clin Res Cardiol, volume 98, pp.121-9.
[22]	Alport A.C., 1927.Hereditary familial congenital haemorrhageic nephritis. Br Med J, Volume 3454, pp. 504-506.
[23]	Van Esch H, Groenen P, Nesbit MA, Schuffenhauer S., 2000. GATA3 haplo-insufficiency causes human HDR syndrome. Nature, volume 406(6794),pp.419-22.
[24]	Kochhar A, Orten DJ, Sorensen JL, Cremers CW.,2008. SIX1 mutation screening in 247 branchio-oto-renal syndrome families: a recurrent missense mutation associated with BOR. Hum. Mutat, volume 29(4), pp.565-68.
[25]	Zarate Y.A, Hopkin R.J., 2008. Fabry's disease. Lancet, volume 372, pp. 1427-1435.
[26]	Kopp, R. P. W. a. J. B., 2007. Genetics of focal segmental glomerulosclerosis. Pediatr Nephrol, 22(5), pp. 638-644.
[27]	Eswari Vilayur, Bamini Gopinath, David C. Harris, George Burlutsky, Catherine M McMahon., 2010. The Association Between Reduced GFR and Hearing Loss: A Cross- sectional Population-Based Study. American Journal of Kidney Disease, volume 56(4), pp. 661-669.
[28]	Shing Rakesh,.2012. Hearing Loss in Chronic Renal Failure, Indian journal of otolaryngology & Head & Neck Surgey, volume 64, pp. 356-359.